Search - Université de Rennes Access content directly

Filter your results

24 Results
Author: personID (integer) : 863504

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

N. Ganne , V. Bourcier , C. Chaffaut , I. Archambaud , F. Oberti et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S213--S214, ⟨10.1016/S0168-8278(15)30057-X⟩
Conference papers hal-01162710v1

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

Alexandre Louvet , Julien Labreuche , Christophe Moreno , Claire Vanlemmens , Romain Moirand et al.
The Lancet Gastroenterology & Hepatology, 2022, 7 (5), pp.416-425. ⟨10.1016/S2468-1253(21)00430-1⟩
Journal articles hal-03594367v1

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

Charlotte Costentin , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (2), pp.431-442.e10. ⟨10.1053/j.gastro.2018.04.027⟩
Journal articles hal-02648451v1

Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines

Alexandre Louvet , Jean-Baptiste Trabut , Christophe Moreno , Romain Moirand , Henri-Jean Aubin et al.
Liver International, 2022, ⟨10.1111/liv.15221⟩
Journal articles hal-03659915v1
Image document

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis

Nathalie Ganne-Carrié , Cendrine Chaffaut , Valérie Bourcier , Isabelle Archambeaud , Jean-Marc Perarnau et al.
Journal of Hepatology, 2018, 69 (6), pp.1274-1283. ⟨10.1016/j.jhep.2018.07.022⟩
Journal articles hal-01880156v1

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

Pierre Nahon , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (5), pp.1436-1450.e6. ⟨10.1053/j.gastro.2018.07.015⟩
Journal articles hal-02648450v1
Image document

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

Manon Allaire , Pierre Nahon , Richard Layese , Valérie Bourcier , Carole Cagnot et al.
Hepatology, 2018, 68 (4), pp.1245-1259. ⟨10.1002/hep.30034⟩
Journal articles hal-02648452v1

Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme

V. Leroy , C. Hezode , S. Metivier , M. Tateo , F. Conti et al.
Journal of Hepatology, 2016, 64 (2), pp.S829. ⟨10.1016/S0168-8278(16)01622-6⟩
Journal articles hal-03590935v1

Drivers of outcome in compensated alcohol-related cirrhosis: a prospective study

Alexandre Louvet , Cendrine Chaffaut , Jerome Gournay , Frederic Oberti , Laure Elkrief et al.
Journal of Hepatology, 2021, 75 (2), pp.S312
Journal articles hal-03946473v1

Sofosbuvir plus Velpatasvir plus Voxilaprevir in Daa Failure Patients with Cirrhosis. Final Results of the French Compassionate Use Program

Christophe Hezode , Dominique Guyader , Eric Nguyen-Khac , Dominique Larrey , Regine Truchi et al.
Hepatology, 2018, 68 (1), pp.374A
Journal articles hal-03590862v1

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

Isabelle Ollivier-Hourmand , Yohann Repesse , Pierre Nahon , Cendrine Chaffaut , Thông Dao et al.
Liver International, 2022, 42 (6), pp.1386-1400. ⟨10.1111/liv.15159⟩
Journal articles hal-03553907v1
Image document

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial

Cyrille Féray , Loic Campion , Philippe Mathurin , Isabelle Archambreaud , Xavier Mirabel et al.
JHEP Reports Innovation in Hepatology, 2023, 5 (4), pp.100689. ⟨10.1016/j.jhepr.2023.100689⟩
Journal articles hal-04044132v1

LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program

C. Hezode , V. de Ledinghen , H. Fontaine , F. Zoulim , P. Lebray et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S265--S266, 2015, ⟨10.1016/S0168-8278(15)30159-8⟩
Conference poster hal-01162768v1

Sofosbuvir plus velpatasvir plus voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program

Christophe Hezode , Dominique Guyader , Eric Nguyen-Khac , Dominique Larrey , Regine Truchi et al.
Journal of Hepatology, 2019, 70 (1, 1), pp.E224. ⟨10.1016/S0618-8278(19)30417-7⟩
Journal articles hal-03590860v1

EARLY LIVER TRANSPLANTATION FOR SEVERE ALCOHOLIC HEPATITIS NOT RESPONDING TO MEDICAL TREATMENT: RESULTS OF THE FRENCH-BELGIAN PROSPECTIVE STUDY QUICKTRANS

Alexandre Louvet , Julien Labreuche , Christophe Moreno , Claire Vanlemmens , Romain Moirand et al.
Hepatology, 2020, 72, pp.4A-5A
Journal articles hal-03036281v1
Image document

Large-scale screening of lipase acid deficiency in at risk population

Abdellah Tebani , Bénédicte Sudrié-Arnaud , Hela Boudabous , Anais Brassier , Rodolphe Anty et al.
Clinica Chimica Acta, 2021, 519, pp.64-69. ⟨10.1016/j.cca.2021.04.005⟩
Journal articles hal-03223991v1

PERSISTENT MODERATE ALCOHOL CONSUMPTION IMPACTS SURVIVAL IN PATIENTS WITH COMPENSATED ALCOHOL-RELATED CIRRHOSIS: ANALYSIS OF THE CIRRAL COHORT.

Alexandre Louvet , Cendrine Chaffaut , Isabelle Archambeaud Mabile , Frederic Oberti , Louis D. Alteroche et al.
Hepatology, 2021, 74 (1), pp.87A-88A
Journal articles hal-03590851v1

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

Christophe Hézode , Victor De Ledinghen , Hélène Fontaine , Fabien Zoulim , Pascal Lebray et al.
Hepatology, 2015, 62, pp.314A--314A. ⟨10.1002/hep.28160⟩
Journal articles hal-01380169v1

RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation

Hicham Bouhlal , Hakim Ouled-Haddou , Veronique Debuysscher , Amrathlal Rabbind Singh , Christele Ossart et al.
Oncotarget, 2016, 7 (9), pp.9832-9843. ⟨10.18632/oncotarget.6954⟩
Journal articles hal-03589698v1
Image document

The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells.

Catherine François , Cédric Coulouarn , Véronique Descamps , Sandrine Castelain , Etienne Brochot et al.
Antimicrobial Agents and Chemotherapy, 2012, 56 (2), pp.903-8. ⟨10.1128/AAC.05646-11⟩
Journal articles hal-00866722v1

The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic Outpatients

Thierry Thévenot , Charline Briot , Vincent Macé , Hortensia Lison , Laure Elkrief et al.
The American Journal of Gastroenterology, 2016, 111 (10), pp.1402-1409. ⟨10.1038/ajg.2016.344⟩
Journal articles hal-03771225v1

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

C. Corpechot , O. Chazouilleres , A. Rousseau , D. Guyader , F. Habersetzer et al.
Journal of Hepatology, 2017, 66 (1, S), pp.S89. ⟨10.1016/S0168-8278(17)30442-7⟩
Journal articles hal-03590930v1

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

Charlotte Costentin , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (2), pp.431-442.e10. ⟨10.1053/j.gastro.2018.04.027⟩
Journal articles hal-04075104v1
Image document

Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status

Etienne Audureau , Fabrice Carrat , Richard Layese , Carole Cagnot , Tarik Asselah et al.
Journal of Hepatology, 2020, 73 (6), pp.1434-1445. ⟨10.1016/j.jhep.2020.05.052⟩
Journal articles hal-03284519v1